Jiang Shichu's pharmaceutical company has applied for a patent for inhibiting PD-1 as a treatment for various cancers, including melanoma, non-small cell lung cancer, renal cell carcinoma, hepatocellular carcinoma, borderline carcinoma, and cervical cancer. This patent application by Jiang Shichu for an immunotherapy drug is the first in China to differentiate cancers based on biomarkers rather than the origin of the tumor.
This technology has always been monopolized by foreign pharmaceutical companies and has not even been imported into China. If you want to treat various cancers with this drug, you basically have to go abroad to buy it. The high travel expenses and drug costs are already unbearable. But at this critical juncture, China has actually started developing the same batch of drugs.
The news from Jiang Shichu shocked the entire industry.
The drug is now in the final stage of clinical trials. If it can stabilize in the final stage, it will not only be a major breakthrough for the domestic medical community, but it is also very likely to become the latest focus for cancer patients around the world, especially those neighboring countries that still do not have this drug.
However, besides shocking the domestic audience, the news made my cousin's expression quite serious.
Jiang Shichu applied for a patent in the final stage, and this drug was also a project that IV Pharmaceuticals had been researching during this period.
If Jiang Shichu's Best Pharmaceuticals successfully passes the clinical trial stage, IV Therapeutics' research on this drug will be in vain, and most of the research expenses invested in the early stage will be wasted. This would be a huge blow to IV Therapeutics.
The news from Bristol Pharmaceuticals was already a bombshell.
Although Ye Zhiwei was not clear about the specifics, she could vaguely sense that there might be some problems with this IV test, and that this terrible situation was due to the success of Bristol Pharmaceuticals.
Peng Yuezeng, who once created several unicorn company myths, also made it clear at this time that Bristol Pharmaceuticals was making waves in the pharmaceutical industry that he would invest in Bristol Pharmaceuticals.
Peng Yuezeng initially invested in IV Pharmaceuticals in his private capacity, but now he has poured all of his financing company's last major investment of the year into Bristol Pharmaceuticals. This move by the old gentleman clearly indicates that he has already favored Bristol Pharmaceuticals.
Ye Zhiwei was also nervous at this moment, especially when she saw the news on TV that not only was Peng Yuezeng an investor in this drug, but Yu Jingchen also seemed to have invested in Baishi early on.
The drug is not yet on the market, but Yu Jingchen's initial investment has already doubled from tens of thousands to hundreds of thousands.
Ye Zhiwei turned off the TV without expression.
Damn it, seeing that bastard Yu Jingchen looking so smug made her angry.
Ji Shuli's situation wasn't good either. He had originally hoped to turn things around with IV, but now some people within the company were making moves. Old Master Ji wasn't the type to dote on his grandson. Apart from Ye Zhiwei, whom he genuinely loved, he was as ruthless as possible towards Ji Shuli. He even directly told Ji Shuli: He was prepared to hand over the company to Ji Shuli, but only if Ji Shuli had the ability. He didn't want his company to ultimately fail in the hands of his unfilial son.
In short: Ji Shuli, if you're capable, take the job; if not, get out.
The young master is under a lot of pressure. He has just graduated and is now facing heavy pressure from Old Master Ji in the board of directors, where he has to survive among a group of old foxes.
Ji Shuli was in a bad mood during dinner that evening, probably because the people on the board of directors made sarcastic remarks about IV, which Ji Shuli had always been optimistic about, and some even suggested that they should take advantage of this wave of popularity to invest in Baishi.
Seeing that Ji Shuli was in a bad mood, Ye Qingcheng shook his head and said, "Shuli, this kind of mentality isn't right. You get discouraged as soon as you encounter some troubles when starting a business. It's normal to encounter troubles when you start from a high point. I did it myself back then—"
Ji Shuli felt slightly comforted and asked with a sigh of relief, "Was Uncle also targeted back then?"
"No, the board of directors thinks I'm capable and will definitely help the Ye Group reach new heights. The main problem is the pressure." Ye Qingcheng smiled, shook his head, and continued, "Fortunately, I withstood the pressure."
Ji Shuli, who had just been comforted, was instantly extinguished again. He looked at Ye Qingcheng expressionlessly and asked, "Uncle, are you really comforting me, or are you just here to show off how great you were back then?"
Ye Qingcheng laughed and said, "I was just trying to lighten the mood."
Ji Shuli: ...
Ye Zhiwei: ...
Only Jiang Jianian remained calm and added a piece of meat for Ye Zhiwei, urging her to eat more.
Seeing that things weren't going well, Song Min smiled and said to Ye Qingcheng, "Children need comforting, what you're doing isn't comforting anyone."
“Ji Shuli has already graduated from university, while Xiao Jiang is only about to become a sophomore. He has such a stable mindset. Even if they really clash with us, we can only see if we can use it in other areas. It may not be as effective, but that doesn’t mean we can’t.” Ye Qingcheng said, praising Jiang Jianian as he spoke.
Since the last incident, Ye Qingcheng has taken a more detached view of things, even becoming somewhat Buddhist. He felt gratified to see Ji Shuli seemingly trying to achieve something to convince the board of directors despite the pressure. He had contacted Old Master Ji to discuss Ji Shuli's situation, but Old Master Ji was very open-minded about the company's affairs. He believed that a group could not achieve stable development without complete monopoly, and all of his shares would definitely be left to Ji Shuli. However, if Ji Shuli lacked ability, Old Master Ji would directly negotiate with the board of directors to convert Ji Shuli's shares into shares without voting rights, thus stripping Ji Shuli of his power on the board.
Mr. Ji hoped for the company's long-term development, rather than its direct monopoly and destruction in the hands of his son. The leadership of a company is crucial. He would certainly ensure that his children would have no worries about food and clothing for the rest of their lives, but he would not allow his life's work, and the Ji Group, which had become a part of society, to be destroyed by his next generation.
The pressure on Ji Shuli is unimaginable. The company's board of directors is also doing its best in cultivating the next generation. After all, Old Master Ji had said in advance that if Ji Shuli is not good enough, then someone else will take his place.
Ji Shuli had a headache, but he wouldn't give up so easily if he were asked to. However, he was under pressure and there was still a long time before the old man gave him the deadline, so he couldn't just give up like that.
What he doesn't understand now is how he just happened to run into Jiang Shichu and his group.
Ye Zhiwei had a vague idea of what was going on, but she couldn't be 100% sure. She could only have someone investigate Qin Manshu's other information again. Now that Baishi Pharmaceuticals had reached such a high level, Qin Manshu was not officially the controller of Baishi Pharmaceuticals, but Ye Zhiwei knew that Qin Manshu was probably the actual controller of the company.
Continue read on readnovelmtl.com